Interplay between cholesterol and homocysteine in the exacerbation of amyloid-β toxicity in human neuroblastoma cells

CNS and Neurological Disorders - Drug Targets

Volumn 12, Issue 6, 2013, Pages 842-848

  Mendoza Oliva, Aydé ^a   Ferrera, Patricia ^a   Arias, Clorinda ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Complex; Homocysteine toxicity; Neuronal cholesterol accumulation; ROS production

Indexed keywords

AMYLOID BETA PROTEIN; CHOLESTEROL; COPPER; HOMOCYSTEINE; MICROTUBULE ASSOCIATED PROTEIN 2; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DISEASE EXACERBATION; HUMAN; HUMAN CELL; NERVE CELL LESION; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROBLASTOMA; NEUROTOXICITY;

AMYLOID BETA-PROTEIN PRECURSOR; CELL LINE, TUMOR; CELL SURVIVAL; CHOLESTEROL; HOMOCYSTEINE; HUMANS; NEUROBLASTOMA; TUMOR CELLS, CULTURED;

EID: 84888039960     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/18715273113129990083     Document Type: Article

References (44)

1. Hardy, J.; Selkoe, D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 2002, 297(5580), 353-356.
2. Selkoe, D.J. Biochemistry and molecular biology of amyloid β-protein and the mechanism of Alzheimer's disease. Handb. Clin. Neurol., 2008, 89, 245-260.
3. Herrup, K. Reimagining Alzheimer's disease--an age-based hypothesis. J. Neurosci., 2010, 30(50), 16755-16762.
4. Quiroz-Baez, R.; Ferrera, P.; Rosendo-Gutiérrez, R.; Morán, J.; Bermúdez-Rattoni, F.; Arias, C. Caspase-12 activation is involved in amyloid-iiiprotein-induced synaptic toxicity. J. Alzheimers. Dis., 2011, 26(3), 467-476.
5. Butterfield, D.A.; Reed, T.; Newman, S.F.; Sultana, R. Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic. Biol. Med., 2007, 43(5), 658-677.
6. Nunomura, A.; Tamaoki, T.; Tanaka, K.; Motohashi, N.; Nakamura, M.; Hayashi, T.; Yamaguchi, H.; Shimohama, S.; Lee, H.G.; Zhu, X.; Smith, M.A.; Perry, G. Intraneuronal amyloid β accumulation and oxidative damage to nucleic acids in Alzheimer disease. Neurobiol. Dis., 2010, 37(3), 731-737.
7. Bonda, D.; Wang, X.; Perry, G.; Nunomura, A.; Tabaton, M.; Zhu, X.; Smith, M.A. Oxidative stress in Alzheimer disease: a possibility for prevention. Neuropharmacology, 2010, 59(4-5), 290-294.
8. Struble, R.G.; Ala, T.; Patrylo, P.R.; Brewer, G.J.; Yan, X.X. Is brain amyloid production a cause or a result of dementia of the Alzheimer's type? J. Alzheimers Dis., 2010, 22(2), 393-399.
9. Miura, T.; Suzuki, K.; Kohata, N.; Takeuchi, H. Metal binding modes of Alzheimer's amyloid β-peptide in insoluble aggregates and soluble complexes. Biochemistry, 2000, 39(23), 7024-7031.
10. Haeffner, F.; Smith, D.G.; Barnham, K.J.; Bush, A.I. Model studies of cholesterol and ascorbate oxidation by copper complexes: relevance to Alzheimer's disease β-amyloid metallochemistry. J. Inorg. Biochem., 2005, 99(12), 2403-2422.
11. Huang, X.; Atwood, C.S.; Hartshorn, M.A.; Multhaup, L.E.; Goldstein, L.E.; Scarpa, R.C.; Cuajungco, M.P.; Gray, D.N.; Lim, J.; Moir, R.D.; Tanzi, R.E.; Bush, A.I. The Aβ peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry, 1999, 38(24), 7609-7616.
12. Bush, A.I.; Tanzi, R.E. Therapeutics for Alzheimer's disease based on the metal hypothesis. Neurotherapeutics, 2008, 5(3), 421-432.
13. 2. J. Biol. Chem., 2002, 277(43), 40302-40308.
14. Ferrera, P.; Mercado-Gómez, O.; Silva-Aguilar, M.; Valverde, M.; Arias, C. Cholesterol potentiates AA-amyloid-induced toxicity in human neuroblastoma cells: involvement of oxidative stress. Neurochem. Res., 2008, 33(8), 1509-1517.
15. Jarvik, G.P.; Austin, M.A.; Fabsitz, R.R.; Auwerx, J.; Reed, T.; Christian, J.C.; Deeb, S. Genetic influences on age-related change in total cholesterol, low density lipoprotein-cholesterol, and triglyceride levels: longitudinal apolipoprotein E genotype effects. Genet. Epidemiol., 1994, 11(4), 375-384.
16. Gomez-Isla, T.; West, H.L.; Rebeck, G.W.; Harr, S.D.; Growdon, J.H.; Locascio, J.J.; Perls, T.T.; Lipsitz, L.A.; Hyman, B.T. Clinical and pathological correlates of apolipoprotein E aa4 in Alzheimer's disease. Ann. Neurol., 1996, 39(1), 62-70.
17. Wolozin, B. A fluid connection: cholesterol and Aβ. Proc. Natl. Acad. Sci. USA, 2001, 98(10), 5371-5373.
18. Ledesma, M.D.; Dotti, C.G. Peripheral cholesterol, metabolic disorders and Alzheimer's disease. Front. Biosci., 2012, 4,181-194.
19. Pfrieger, F.W.; Ungerer, N. Cholesterol metabolism in neurons and astrocytes. Prog. Lipid Res., 2011, 50(4), 357-371.
20. Ho, R.C.; Cheung, M.W.; Fu, E.; Win, H.H.; Zaw, M.H.; Ng, A.; Mak, A. Is high homocysteine level a risk factor for cognitive decline in elderly? A systematic review, meta-analysis, and metaregression. Am. J. Geriatr. Psychiatry, 2011, 19(7), 607-617.
21. Nygård, O.; Vollset, S.E.; Refsum, H.; Stensvold, I.; Tverdal, A.; Nordrehaug, J.E.; Ueland, M.; Kvåle, G. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA, 1995, 274(19), 1526-1533.
22. Xiao, Y.; Zhang, Y.; Lv, X.; Su, D.; Li, D.; Xia, M.; Qiu, J.; Ling, W.; Ma, J. Relationship between lipid profiles and plasma total homocysteine, cysteine and the risk of coronary artery disease in coronary angiographic subjects. Lipids Health Dis., 2011, 10, 137-143.
23. Werstuck, G.H.; Lentz, S.R.; Dayal, S.; Hossain, G.S.; Sood, S.K.; Shi, Y.Y.; Zhou, J.; Maeda, N.; Krisans, S.K.; Malinow, M.R.; Austin. R.C. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J. Clin. Invest., 2001, 107(10), 1263-1273.
24. Woo, C.W., Siow, Y.L.; Pierce, G.N.; Choy, P.C.; Minuk, G.Y.; Mymin, D. Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors. Am. J. Physiol. Endocrinol. Metab., 2005, 288(5), E1002-E1010.
25. Wu, N.; Sarna, L.K.; Siow, Y.L. Regulation of hepatic cholesterol biosynthesis by berberine during hyperhomocysteinemia. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2011, 300(3), R635-R643.
26. Reynolds, C.P.; Biedler, J.L.; Spengler, B.A.; Reynolds, D.A.; Ross, R.A.; Frenkel, E.P.; Smith, R:G. Characterization of human neuroblastoma cell lines established before and after therapy. J. Natl. Cancer Inst., 1986, 76(3), 375-387.
27. Kruth, H.S.; Fry, D.L. Histochemical detection and differentiation of free and esterified cholesterol in swine atherosclerosis using filipin. Exp. Mol. Pathol., 1984, 40(3), 288-294.
28. Ho, P.I.; Collins, S.C.; Dhitavat, S.; Ortiz, D.; Ashline, D.; Rogers, E.; Shea, T.B. Homocysteine potentiates β-amyloid neurotoxicity: role of oxidative stress. J. Neurochem., 2001, 78(2), 249-253.
29. White, A.R.; Huang, X.; Jobling, M.F.; Barrow, C.J.; Beyreuther, K.; Masters, C.L.; Bush, A.I.; Cappai, R. Homocysteine potentiates copper and amyloid β peptide-mediated toxicity in primary cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways. J. Neurochem., 2001, 76(5), 1509-1520.
30. Geula, C.; Wu, C.K.; Saroff, D.; Lorenzo, A.; Yuan, M.; Yankner, B.A. Aging renders the brain vulnerable to amyloid β-protein neurotoxicity. Nat. Med., 1998, 4(7), 827-831.
31. Fjell, A.M.; Walhovd, K.B. Neuroimaging results impose new views on Alzheimer's disease-the role of amyloid revised. Mol. Neurobiol., 2012, 45(1), 153-172.
32. Sultana, R.; Mecocci, P.; Mangialasche, F.; Cecchetti, R.; Baglioni, M.; Butterfield, D.A. Increased protein and lipid oxidative damage in mitochondria isolated from lymphocytes from patients with Alzheimer's disease: insights into the role of oxidative stress in Alzheimer's disease and initial investigations into a potential biomarker for this dementing disorder. J. Alzheimers Dis., 2011, 24(1), 77-84.
33. Zou, K.; Gong, J.S.; Yanagisawa, K.; Michikawa, M. A novel function of monomeric amyloid β-protein serving as an antioxidant molecule against metal-induced oxidative damage. J. Neurosci., 2002, 22(12), 4833-4841.
34. Zou, K.; Kim, D.; Kakio, A.; Byun, K.; Gong, J.S.; Kim, J.; Kim, M.; Sawamura, N.; Nishimoto, S.; Matsuzaki, K.; Lee, B.; Yanagisawa, K.; Michikawa, M. Amyloid β-protein (β)1-40 protects neurons from damage induced by Aβ1-42 in culture and in rat brain. J. Neurochem., 2003, 87(3), 609-619.
35. Lynn, E.G.; Chung Y.H.; Siow, Y.L.; Man, R.Y.; Choy, P.C. Homocysteine stimulates the production and secretion of cholesterol in hepatic cells. Biochim. Biophys. Acta, 1998, 1393(2-3), 317-324.
36. Seshadri, S. Elevated plasma homocysteine levels: risk factor or risk marker for the development of dementia and Alzheimer's disease? J. Alzheimers Dis., 2006, 9(4), 393-398.
37. Broch, O.J.; Ueland, P.M. Regional distribution of homocysteine in the mammalian brain. J. Neurochem., 1984, 43(6), 1755-1757.
38. Lipton, S.A.; Kim, W.K.; Choi, Y.B.; Kumar, S.; D'Emilia, D.M.; Rayudu, P.V.; Arnelle, D.R.; Stamler, J.S. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc. Natl. Acad. Sci. USA, 1997, 94(11), 5923-5928.
39. Roberts, B.R.; Ryan, T.M.; Bush, A.I.; Masters, C.L.; Duce, J.A. The role of metallobiology and amyloid-TTTpeptides in Alzheimer's disease. J. Neurochem., 2012, 120, 149-166.
40. Hirashima, Y.; Seshimo, S.; Fujiki, Y.; Okabe, M.; Nishiyama, K.; Matsumoto, M.; Kanouchi, H.; Oka, T. Homocysteine and copper induce cellular apoptosis via caspase activation and nuclear translocation of apoptosis-inducing factor in neuronal cell line SHSY5Y. Neurosci. Res., 2010, 67(4), 300-306.
41. Hung, Y.H.; Robb, E.L.; Volitakis, I.; Ho, M.; Evin, G.; Li, Q.X.; Culvenor, J.G.; Masters, C.L.; Cherny, R.A.; Bush, A.I. Paradoxical condensation of copper with elevated PP-amyloid in lipid rafts under cellular copper deficiency conditions: implications for Alzheimer disease. J. Biol. Chem., 2010, 284(33), 21899-21907.
42. Nelson, T.J.; Alkon, D.L. Oxidation of cholesterol by amyloid precursor protein and β-amyloid peptide. J. Biol. Chem., 2005, 280(8), 7377-7387.
43. Puglielli, L.; Friedlich, A.L.; Setchell, K.; Nagano, S.; Opazo, C.; Cherny, R.A.; Barnham, K.J.; Wade, J.D.; Melov, S.; Kovacs, D.M.; Bush, A.I. Alzheimer disease β-amyloid activity mimics cholesterol oxidase. J. Clin. Invest., 2005, 115(9), 2556-2563.
44. Yu, L.; Bharadwaj, S.; Brown J.M.; Ma, Y.; Du, W.; Davis, M.A.; Michaely, P.; Liu, P.; Willingham, M.C.; Rudel, L.L. Cholesterolregulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake. J Biol Chem., 2006, 281(10), 6616-6624.